GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (OTCPK:PMCUF) » Definitions » COGS-to-Revenue

Pro Medicus (Pro Medicus) COGS-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Pro Medicus COGS-to-Revenue?

Pro Medicus's Cost of Goods Sold for the six months ended in Dec. 2023 was $0.11 Mil. Its Revenue for the six months ended in Dec. 2023 was $49.58 Mil.

Pro Medicus's COGS to Revenue for the six months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pro Medicus's Gross Margin % for the six months ended in Dec. 2023 was 99.77%.


Pro Medicus COGS-to-Revenue Historical Data

The historical data trend for Pro Medicus's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus COGS-to-Revenue Chart

Pro Medicus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.01 0.01 - -

Pro Medicus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - 0.01 - -

Pro Medicus COGS-to-Revenue Calculation

Pro Medicus's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.36499999999999 / 83.75
=0.00

Pro Medicus's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.114 / 49.581
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus  (OTCPK:PMCUF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pro Medicus's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.114 / 49.581
=99.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Pro Medicus COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pro Medicus's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus (Pro Medicus) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Pro Medicus (Pro Medicus) Headlines

From GuruFocus

Visage Introduces Semantic Annotations for Visage 7

By PRNewswire PRNewswire 12-01-2019

Visage 7.1.15 Now Available

By PRNewswire PRNewswire 06-26-2020

Visage Announces Support of Amazon HealthLake Imaging

By PRNewswire PRNewswire 11-27-2022

Visage Joins the AWS Partner Network

By PRNewswire PRNewswire 06-27-2022

Visage Signs Ludwig-Maximilians-Universit�t for PACS

By PRNewswire PRNewswire 10-16-2020

Proven Enterprise Imaging with Visage at RSNA 2018

By PRNewswire PRNewswire 11-14-2018

Visage Soars with CloudPACS at RSNA 2023

By PRNewswire 11-14-2023

Breast Imaging Excels with Visage at 2018 SBI

By PRNewswire PRNewswire 04-12-2018

Visage 7 Named Best in KLAS 2023

By PRNewswire PRNewswire 02-08-2023

Visage Introduces Visage 7 Video Reports at RSNA21

By PRNewswire PRNewswire 11-23-2021